Jan‐Willem Henning

1.1k total citations
29 papers, 327 citations indexed

About

Jan‐Willem Henning is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jan‐Willem Henning has authored 29 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Jan‐Willem Henning's work include Advanced Breast Cancer Therapies (10 papers), Cancer Treatment and Pharmacology (9 papers) and HER2/EGFR in Cancer Research (8 papers). Jan‐Willem Henning is often cited by papers focused on Advanced Breast Cancer Therapies (10 papers), Cancer Treatment and Pharmacology (9 papers) and HER2/EGFR in Cancer Research (8 papers). Jan‐Willem Henning collaborates with scholars based in Canada, United States and Italy. Jan‐Willem Henning's co-authors include Giampaolo Bianchini, Javier Cortés, Michael Untch, Hope S. Rugo, Mohamad Baydoun, Julie M. Deleemans, Katherine-Ann Piedalue, Raylene A. Reimer, Linda E. Carlson and Faye Chleilat and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Jan‐Willem Henning

26 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan‐Willem Henning Canada 9 185 134 64 52 33 29 327
Jun Won Min South Korea 10 155 0.8× 76 0.6× 35 0.5× 54 1.0× 12 0.4× 40 331
Michael A. Samuels United States 12 159 0.9× 141 1.1× 81 1.3× 41 0.8× 12 0.4× 35 419
N.K. Shukla India 10 132 0.7× 116 0.9× 43 0.7× 25 0.5× 17 0.5× 35 329
Jéssica Schuster United States 10 103 0.6× 63 0.5× 37 0.6× 138 2.7× 12 0.4× 32 379
Ashok R. Jethwa Canada 8 149 0.8× 71 0.5× 81 1.3× 34 0.7× 14 0.4× 14 445
Mary Nguyen-Nielsen Denmark 10 107 0.6× 121 0.9× 133 2.1× 25 0.5× 11 0.3× 13 389
Nedal Bukhari Saudi Arabia 7 187 1.0× 91 0.7× 72 1.1× 14 0.3× 7 0.2× 22 339
Jackie Charman United Kingdom 7 154 0.8× 112 0.8× 27 0.4× 17 0.3× 14 0.4× 16 287
John Thomas Helgstrand Denmark 11 85 0.5× 247 1.8× 41 0.6× 62 1.2× 20 0.6× 24 316
David Skarsgard Canada 13 112 0.6× 205 1.5× 28 0.4× 68 1.3× 13 0.4× 25 450

Countries citing papers authored by Jan‐Willem Henning

Since Specialization
Citations

This map shows the geographic impact of Jan‐Willem Henning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan‐Willem Henning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan‐Willem Henning more than expected).

Fields of papers citing papers by Jan‐Willem Henning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan‐Willem Henning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan‐Willem Henning. The network helps show where Jan‐Willem Henning may publish in the future.

Co-authorship network of co-authors of Jan‐Willem Henning

This figure shows the co-authorship network connecting the top 25 collaborators of Jan‐Willem Henning. A scholar is included among the top collaborators of Jan‐Willem Henning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan‐Willem Henning. Jan‐Willem Henning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brezden‐Masley, Christine, et al.. (2025). Clinician’s guide: expert insights on the use of CDK4/6 inhibitors in patients with early breast cancer. Therapeutic Advances in Medical Oncology. 17. 22771446–22771446.
2.
3.
4.
Gelmon, Karen A., Jean-François Boileau, Christine Brezden‐Masley, et al.. (2024). Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Setting. Current Oncology. 31(11). 6536–6567. 1 indexed citations
5.
Beecroft, J. Robert, Savtaj S. Brar, Xiaolan Feng, et al.. (2024). Pan-Canadian consensus recommendations for GIST management in high- and low-throughput centres across Canada. Therapeutic Advances in Medical Oncology. 16. 12710915–12710915. 1 indexed citations
6.
Cao, Jeffrey, Jean-François Boileau, Karen A. Gelmon, et al.. (2024). Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer. Current Oncology. 31(11). 7226–7243. 2 indexed citations
7.
Boyne, Devon J., et al.. (2024). Treatment Patterns and Health Outcomes among Patients with HER2 IHC0/-Low Metastatic or Recurrent Breast Cancer. Cancers. 16(3). 518–518. 3 indexed citations
8.
Brezden‐Masley, Christine, Anil A. Joy, Sandeep Sehdev, et al.. (2023). Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigm. Therapeutic Advances in Medical Oncology. 15. 2620176–2620176. 8 indexed citations
9.
Henning, Jan‐Willem, Christine Brezden‐Masley, Karen A. Gelmon, et al.. (2023). Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective. Current Oncology. 30(9). 8019–8038. 17 indexed citations
10.
Henning, Jan‐Willem, et al.. (2023). Clinical Considerations for the Integration of Adjuvant Olaparib into Practice for Early Breast Cancer: A Canadian Perspective. Current Oncology. 30(8). 7672–7691. 3 indexed citations
11.
Jafri, Mariam, Jan‐Willem Henning, Kelly Davison, et al.. (2023). Accrual of adolescents and young adults (AYA) into cancer clinical trials in Canada.. Journal of Clinical Oncology. 41(16_suppl). e13598–e13598.
12.
Heer, Emily, Yibing Ruan, Devon J. Boyne, et al.. (2023). Impact of the COVID-19 pandemic on cancer diagnoses, stage and survival in Alberta. Canadian Medical Association Journal. 195(23). E804–E812. 17 indexed citations
13.
Deleemans, Julie M., Faye Chleilat, Raylene A. Reimer, et al.. (2022). The Chemo-Gut Pilot Study: Associations between Gut Microbiota, Gastrointestinal Symptoms, and Psychosocial Health Outcomes in a Cross-Sectional Sample of Young Adult Cancer Survivors. Current Oncology. 29(5). 2973–2994. 22 indexed citations
14.
Rugo, Hope S., Giampaolo Bianchini, Javier Cortés, Jan‐Willem Henning, & Michael Untch. (2022). Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer. ESMO Open. 7(4). 100553–100553. 78 indexed citations
15.
Moss, Stephana J., Andrew Harper, Jan‐Willem Henning, et al.. (2021). Data Resource Profile: The Alberta Adolescent and Young Adult Cancer Survivor Study. International Journal of Epidemiology. 51(3). e55–e64. 3 indexed citations
16.
Henning, Jan‐Willem, et al.. (2021). Craniospinal Irradiation for Leptomeningeal Disease in Recurrent Breast Cancer. 42–47. 2 indexed citations
17.
Kazemi, Ghazaleh, Tina Hsu, Oren Levine, et al.. (2020). Implementing Changes to a Residency Program Curriculum before Competency-Based Medical Education: A Survey of Canadian Medical Oncology Program Directors. Current Oncology. 27(6). 614–620. 4 indexed citations
18.
19.
Henning, Jan‐Willem, Elizabeth Kurien, Don Morris, et al.. (2018). Surgical excision versus observation as initial management of desmoid tumors: A population based study. European Journal of Surgical Oncology. 45(4). 699–703. 30 indexed citations
20.
Califaretti, Nadia, Nathaniel Bouganim, Susan Dent, et al.. (2016). Treat ER+ight: Treatment of Canadian postmenopausal women with ER+ HER2- advanced breast cancer in the real-world setting with hormone therapy ± targeted therapy.. Journal of Clinical Oncology. 34(15_suppl). TPS614–TPS614. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Won Min Breakdown of academic impact, for papers by Michael A. Samuels Breakdown of academic impact, for papers by N.K. Shukla Breakdown of academic impact, for papers by Jéssica Schuster Breakdown of academic impact, for papers by Ashok R. Jethwa Breakdown of academic impact, for papers by Mary Nguyen-Nielsen Breakdown of academic impact, for papers by Nedal Bukhari Breakdown of academic impact, for papers by Jackie Charman Breakdown of academic impact, for papers by John Thomas Helgstrand Breakdown of academic impact, for papers by David Skarsgard
Rankless by CCL
2026